NATURESPACE GROUP LIMITED
Company number 15112361 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
NATURESPACE GROUP LIMITED - Analysis Report
Company Number: 15112361
Analysis Date: 2025-07-29 20:35 UTC
Financial Health Assessment for NATURESPACE GROUP LIMITED
1. Financial Health Score: D (Distressed Condition)
Explanation:
This company shows signs of significant financial distress as indicated by negative net current assets (working capital) and net liabilities position. The balance sheet reveals that current liabilities far exceed current assets, a symptom akin to a patient showing signs of acute liquidity stress. Immediate attention is required to restore financial viability.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 4,823 | Very low; typical for a micro-entity, indicating minimal long-term investments. |
| Current Assets | 42,844 | Low level of liquid and short-term assets available. |
| Current Liabilities | 249,858 | Very high relative to assets, indicating heavy short-term obligations. |
| Net Current Assets (Working Capital) | -207,014 | Severe liquidity imbalance; company owes more than it owns in short term. |
| Total Assets Less Current Liabilities | -202,191 | Negative figure; "health" of the asset base is poor after short-term debts. |
| Net Assets (Shareholders’ Funds) | -208,524 | Negative equity; company is insolvent on a balance sheet basis. |
| Average Number of Employees | 2 | Small workforce consistent with micro-entity status. |
Interpretation:
- The "vital signs" reveal critical liquidity and solvency issues: the company is unable to cover its short-term debts with available current assets, a classic symptom of financial distress.
- Negative net assets imply that the company’s total liabilities surpass total assets, a symptom comparable to serious organ failure in a patient.
- Small fixed assets and workforce size align with a micro-entity status, but these do not compensate for the poor liquidity position.
3. Diagnosis
Underlying Business Health Analysis:
- The company is relatively new (incorporated in Sept 2023) and classified as a micro-entity.
- Despite this, the financial snapshot at the end of 2024 shows a severe liquidity crisis, with current liabilities nearly six times current assets.
- Such a mismatch suggests either accumulated unpaid debts, aggressive short-term financing, or possibly delayed payments from customers (debtors).
- The negative shareholders’ funds highlight an insolvency situation on paper, indicating the business may be relying on external support (e.g., shareholder loans or credit lines) to continue operations.
- The current directors and significant shareholders control the company, but one director resigned early in 2024; this could suggest internal restructuring or governance changes.
- The small employee base and micro-entity classification limit detailed financial disclosures, but the available data signals urgent financial strain and a risk of going under without intervention.
4. Recommendations
Actions to improve financial wellness:
Immediate Cash Flow Management:
- Conduct a detailed cash flow forecast to identify critical shortfalls.
- Accelerate collections from debtors and negotiate extended terms with creditors to ease immediate cash pressure.
Restructure Liabilities:
- Engage creditors proactively to restructure short-term debts into longer-term obligations if possible.
- Explore emergency financing options such as director loans or external investors.
Cost Control and Efficiency:
- Review operating expenses and reduce non-essential costs to preserve cash.
- Ensure staffing levels and overheads align with current revenue generation capacity.
Financial Monitoring and Reporting:
- Implement tighter financial controls and more frequent management accounts to detect issues early.
- Consider seeking professional financial advisory support to guide turnaround efforts.
Strategic Review:
- Evaluate the business model viability and market position to determine if pivot or business plan revision is needed.
- Consider potential capital injections or sale of non-core assets if any.
Medical Analogy Summary
The company’s financial condition resembles a patient with dangerously low blood pressure and compromised organ function—it is struggling to meet short-term obligations ("healthy cash flow") and is technically insolvent ("negative net assets"). Without immediate intervention akin to emergency treatment, the prognosis is poor.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.